Atlas Trials

Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer

Clinical trial NCT02288936 · COMPLETED

Trial details

NCT number
NCT02288936
Sponsor
Spanish Oncology Genito-Urinary Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone-refractory Prostate Cancer
Start date
2015-02-05
Primary completion
2019-07-22
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.